Hab Pharmaceuticals & Research is rapidly advancing as a key player in the off-patent pharmaceutical landscape. The company has focused on developing high-quality, affordable versions of essential medicines, addressing the increasing demand for cost-effective healthcare solutions. With a commitment to advancement and strict quality oversight, this

Hab Pharmaceuticals & Research Ltd, a leading drug organization, maintains its considerable presence in local market. Established during 1995, the firm steadily developed as a major player, specializing on developing reliable affordable medications. Its developmental activities include on multiple therapeutic sectors, such as heart-related diseases